Infusive Asset Management’s Colgate-Palmolive CL Stock Holding History

Infusive Asset Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.08M	Sell	47,816 -10,681	-18%	-$952K	1.97%	22
2025 Q4	$4.62M	Sell	58,497 -891	-2%	-$69.9K	1.97%	23
2025 Q3	$4.75M	Sell	59,388 -1,321	-2%	-$113K	2.18%	19
2025 Q2	$5.52M	Sell	60,709 -1,256	-2%	-$115K	2.46%	15
2025 Q1	$5.81M	Sell	61,965 -15,650	-20%	-$1.4M	2.69%	14
2024 Q4	$7.06M	Buy	77,615 +68,429	+745%	+$6.53M	3.14%	14
2024 Q3	$954K	Hold	9,186	–	–	0.4%	37
2024 Q2	$891K	Buy	+9,186	New	+$847K	0.36%	33
2022 Q2	–	Sell	-2,535	Closed	-$192K	–	17
2022 Q1	$192K	Sell	2,535 -610	-19%	-$48.3K	0.09%	24
2021 Q4	$268K	Sell	3,145 -215	-6%	-$16.8K	0.09%	31
2021 Q3	$254K	Sell	3,360 -125	-4%	-$9.93K	0.05%	34
2021 Q2	$284K	Sell	3,485 -416	-11%	-$34K	0.06%	42
2021 Q1	$308K	Buy	3,901 +468	+14%	+$36.7K	0.07%	33
2020 Q4	$294K	Buy	+3,433	New	+$284K	0.1%	30

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Infusive Asset Management's CL Position: Q1 2026 in Review

Infusive Asset Management reduced its Colgate-Palmolive (CL) stake by 18% in Q1 2026, selling an estimated $952K and leaving 47,816 shares worth $4.08M. The position accounts for 1.97% of the portfolio, ranked #22.

Infusive Asset Management first reported a position in CL in Q4 2020 and has held it in 14 quarters since. The position peaked at $7.06M in Q4 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Infusive Asset Management held 47,816 shares of Colgate-Palmolive worth $4.08M as of Q1 2026.
Infusive Asset Management sold 10,681 Colgate-Palmolive shares in Q1 2026, an estimated $952K.
Colgate-Palmolive made up 1.97% of Infusive Asset Management's portfolio in Q1 2026, its #22 holding.
Infusive Asset Management first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 14 quarters since.
Infusive Asset Management's Colgate-Palmolive position peaked at $7.06M in Q4 2024.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Infusive Asset Management's 13F filing for Q1 2026, filed 14 May 2026.